4//SEC Filing
INTROGEN THERAPEUTICS INC 4
Accession 0001257433-07-000019
CIK 0001018710operating
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 1:50 PM ET
Size
7.9 KB
Accession
0001257433-07-000019
Insider Transaction Report
Form 4
ALBRECHT JAMES W JR
Chief Executive Officer
Transactions
- Other
stock option
2007-07-31+57,600→ 0 totalExercise: $0.45From: 1997-08-01Exp: 2007-07-31→ common stock (57,600 underlying) - Award
common stock
2007-10-01$0.00/sh+32,661$33→ 53,461 total
Footnotes (4)
- [F1]This represents the net number of shares issued to Mr. Albrecht after withholding a number of shares with a value equal to his tax obligation with respect to the shares acquired.
- [F2]The purchase price for the shares has been paid by the reporting person via services previously rendered to the Company. The $0.001 represents the par value per share.
- [F3]Right to buy.
- [F4]On July 31, 2007, options held by reporting person to purchase 57,600 shares of Company common stock expired prior to any exercise thereof. Pursuant to Exchange Act Rule 16a-4(d), the expiration of such options for no value is not reportable. Reporting person is voluntarily reporting such expiration.
Documents
Issuer
INTROGEN THERAPEUTICS INC
CIK 0001018710
Entity typeoperating
Related Parties
1- filerCIK 0001018710
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 1:50 PM ET
- Size
- 7.9 KB